These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21549463)

  • 1. High-normal albuminuria and risk of heart failure in the community.
    Blecker S; Matsushita K; Köttgen A; Loehr LR; Bertoni AG; Boulware LE; Coresh J
    Am J Kidney Dis; 2011 Jul; 58(1):47-55. PubMed ID: 21549463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.
    Ferreira JP; Zannad F; Butler J; Filippatos G; Pocock SJ; Brueckmann M; Steubl D; Schueler E; Anker SD; Packer M
    JAMA Cardiol; 2022 Nov; 7(11):1148-1159. PubMed ID: 36129693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuminuria in chronic heart failure: prevalence and prognostic importance.
    Jackson CE; Solomon SD; Gerstein HC; Zetterstrand S; Olofsson B; Michelson EL; Granger CB; Swedberg K; Pfeffer MA; Yusuf S; McMurray JJ;
    Lancet; 2009 Aug; 374(9689):543-50. PubMed ID: 19683640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes.
    Tao J; Sang D; Zhen L; Zhang X; Li Y; Wang G; Chen S; Wu S; Zhang W
    Cardiovasc Diabetol; 2023 Mar; 22(1):70. PubMed ID: 36966320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.
    Bansal N; Zelnick LR; Alonso A; Benjamin EJ; de Boer IH; Deo R; Katz R; Kestenbaum B; Mathew J; Robinson-Cohen C; Sarnak MJ; Shlipak MG; Sotoodehnia N; Young B; Heckbert SR
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1386-1398. PubMed ID: 28798221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ishigami J; Grams ME; Naik RP; Coresh J; Matsushita K
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1735-1743. PubMed ID: 27515592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study.
    Waheed S; Matsushita K; Sang Y; Hoogeveen R; Ballantyne C; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):207-16. PubMed ID: 22537422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
    Gerstein HC; Mann JF; Yi Q; Zinman B; Dinneen SF; Hoogwerf B; Hallé JP; Young J; Rashkow A; Joyce C; Nawaz S; Yusuf S;
    JAMA; 2001 Jul; 286(4):421-6. PubMed ID: 11466120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality.
    Sung KC; Ryu S; Lee JY; Lee SH; Cheong E; Hyun YY; Lee KB; Kim H; Byrne CD
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria: Associated With Heart Failure Severity and Impaired Clinical Outcomes.
    Shuvy M; Zwas DR; Lotan C; Keren A; Gotsman I
    Can J Cardiol; 2020 Apr; 36(4):527-534. PubMed ID: 31926740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction.
    Katz DH; Burns JA; Aguilar FG; Beussink L; Shah SJ
    JACC Heart Fail; 2014 Dec; 2(6):586-96. PubMed ID: 25282032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial.
    Muskiet MHA; Tonneijck L; Huang Y; Liu M; Saremi A; Heerspink HJL; van Raalte DH
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):859-869. PubMed ID: 30292589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
    Arnlöv J; Evans JC; Meigs JB; Wang TJ; Fox CS; Levy D; Benjamin EJ; D'Agostino RB; Vasan RS
    Circulation; 2005 Aug; 112(7):969-75. PubMed ID: 16087792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
    Dal Canto E; Elders PJM; van der Heijden AA; van Ballegooijen AJ; Lissenberg-Witte BI; Rutters F; Beulens JWJ
    Diabetologia; 2023 Mar; 66(3):482-494. PubMed ID: 36347992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults.
    Bailey LN; Levitan EB; Judd SE; Sterling MR; Goyal P; Cushman M; Safford MM; Gutiérrez OM
    JACC Heart Fail; 2019 May; 7(5):394-401. PubMed ID: 31047019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
    Vaduganathan M; Pareek M; Kristensen AMD; Biering-Sørensen T; Byrne C; Almarzooq Z; Olesen TB; Olsen MH; Bhatt DL
    Eur J Heart Fail; 2021 Mar; 23(3):384-392. PubMed ID: 33448580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals.
    Brown JR; Katz R; Ix JH; de Boer IH; Siscovick DS; Grams ME; Shlipak M; Sarnak MJ
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):239-46. PubMed ID: 24262510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Hauske SJ; Brodovicz KG
    J Diabetes Complications; 2018 Mar; 32(3):291-297. PubMed ID: 29352693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.